REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/04/2025
Voltar para busca
Dado oficial do USPTO
BENEVOLENTAI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BENEVOLENTAI
ST13
US500000079255966Classe
5, 9, 10, 41, 42, 44
Pedido
79255966
Registro
6026106
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
08/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 41, 42, 44
Data de depósito
05/02/2019
Data de registro
07/04/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/04/2020
Última transação
08/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
24
Localização do titular
GB
Examinador
DANTZLER, LAUREN
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BenevolentAI Limited
Representantes
Leigh Ann Lindquist Sughrue Mion PLLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of central nervous system CNS diseases; pharmaceutical preparations acting on the central nervous system; medicines for the treatment of diseases affecting the central nervous system; medicines for veterinary purposes in the nature of antibiotics; antibiotics for human use; antibiotics for veterinary use; antibiotic food supplements for animals; chemical reagents for medical use; chemical reagents for veterinary use; central nervous system stimulants; nutritional supplements; nutritional supplements for veterinary use; vitamin and mineral supplements; vitamin supplements for animals; veterinary vaccines
Classe 9
Artificial intelligence apparatuscomputer hardware and recorded software for implementing artificial intelligence in products and services; downloadable artificial intelligence software for searchingtrackingexploration and analysis of data for use in the field of healthcare; downloadable artificial intelligence software for searchingtrackingexploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines
Classe 10
Medical instruments for therapeutic drug monitoring; testing apparatus for DNA and RNA testing for medical purposes
Classe 41
Library services provided by means of a computerized database; library servicesproviding electronic library services featuring data stored and retrieved by electronic means; publication of books; publication of journals; publication of electronic books and journals online; publication of material in the nature of electronic books and journals which can be accessed from databases or from the Internet; publication of the results of clinical trials for pharmaceutical preparations in the field of diseases affecting the central nervous system; publication of the results of clinical trials for pharmaceutical preparations
Classe 42
Design and development of computer software; providing online non-downloadable computer software for searchingtrackingexploration and analysis of data for use in the field of healthcare; providing online non-downloadable computer software for searchingtrackingexploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Platform as a Service PaaSproviding artificial intelligence software platforms for searchingtrackingexploration and analysis of data for use in the field of healthcare; Platform as a Service PaaSproviding artificial intelligence software platforms for searchingtrackingexploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Software as a Service SaaSproviding artificial intelligence software for searchingtrackingexploration and analysis of data for use in the field of healthcare; Software as a Service SaaSproviding artificial intelligence software for searchingtrackingexploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; hosting of digital content online; hosting of digital contentonline journals; computer programming; writing of computer programs for medical applications; writing of computer programs for biotechnological applications; writing of data processing programs; scientific and medical research and development services; scientific research conducted using databases and the Internet; medical research services; pharmaceutical research and development services; pharmaceutical product evaluation; research and development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; drug discovery services; services for assessing the efficiency of veterinary drugs; services for assessing the efficiency of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of pharmaceutical research and development; information technology consulting services for the pharmaceutical and healthcare industries; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing informationadvisory and consultancy services regarding information technology services for the pharmaceutical and healthcare industriesall of the aforesaid services also provided online via a database or the Internet; providing informationadvisory and consultancy services regarding research and development of pharmaceutical preparations and medicinesall of the aforesaid services also provided online via a database or the Internet; providing information and data relating to veterinary research and developmentall of the aforesaid services also provided online via a database or the Internet
Classe 44
Healthcare informationadvisory and consultancy services; medical services; medical informationadvisory and consultancy services; medical testing for diagnostic or treatment purposes; consulting services in the fields of pharmaceutical research and development; providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; consulting and advisory services in the fields of pharmaceutical research and development; veterinary services; veterinary informationadvisory and consultancy services; collation of information in the healthcare sector; providing medical information in the healthcare sector; providing medical information concerning pharmaceuticals and the research and development of pharmaceuticalsall of the aforesaid services also provided online via a database or the Internet
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/07/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/07/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
15/07/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/07/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/07/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
15/07/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
16/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/03/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
16/03/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/08/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/08/2020
FIMP
FINAL DISPOSITION PROCESSED
12/08/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/07/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/01/2020
PUBO
PUBLISHED FOR OPPOSITION
21/01/2020
GPNX
NOTIFICATION PROCESSED BY IB
17/01/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/01/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
ALIE
ASSIGNED TO LIE
19/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
18/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
18/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/12/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
18/12/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2019
RFNT
REFUSAL PROCESSED BY IB
01/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/05/2019
RFRR
REFUSAL PROCESSED BY MPU
11/05/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/04/2019
CNRT
NON-FINAL ACTION WRITTEN
20/04/2019
DOCK
ASSIGNED TO EXAMINER
17/04/2019
MAFR
APPLICATION FILING RECEIPT MAILED
12/04/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/04/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/04/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BENEVOLENTAI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.